The invention relates to the identification of genetic products that areexpressed in associationwith a tumor and the nucleic acid coding therefor. The invention relates tothe therapy anddiagnosis of diseases in which said genetic products that are expressed inassociation with atumor are expressed in an aberrant manner. The invention also relates toproteins, polypeptides,and peptides which are expressed in association with a tumor and the nucleicacids codingtherefor.